2021 annual financial data
Capricor Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -6,863.81%.
Operating income was -20,938,442 USD and net income was -20,022,520 USD.
Operating cash flow was -16,809,324 USD.
Get free Capricor Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 244,898 USD
- Operating income
- -20,938,442 USD
- Net income
- -20,022,520 USD
- Operating cash flow
- -16,809,324 USD